Mainstream

Inmed Pharmaceuticals Gaap Eps Of $3.64, Revenue Of $1.11m

InMed Pharmaceuticals GAAP EPS of -$3.64, revenue of $1.11M

InMed Pharmaceuticals GAAP EPS of -$3.64, revenue of $1.11M

Post Contentinm, in:caRead More

You might also be interested in reading Swiss-based Digital Assets AG launches tokenized stock offerings on Solana.

February 13, 2025
In Mainstream